SCHEMBL19925327

SCHEMBL19925327

B.C=CP(OCc1ccccc1[N+](=O)[O-])OCc1ccccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HTT P42858 2/20 0.48
TSHR P16473 1/20 0.47
HPGD P15428 1/20 0.44
MAOB P27338 1/20 0.44
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RECQL P46063 1/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29570427 0.98 ALDH1A1 (0.49) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL29199389 0.78 ALDH1A1 (0.45) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL6045645 0.78 ALDH1A1 (0.53) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL10389234 0.78 ALDH1A1 (0.53) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL29199366 0.78 ALDH1A1 (0.53) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL291637 0.75 ALDH1A1 (0.58) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL6045653 0.75 ALDH1A1 (0.50) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL6045647 0.75 ALDH1A1 (0.50) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL10404273 0.75 ALDH1A1 (0.50) ALDH1A1HTTTSHRHPGDMAOB
SCHEMBL7858248 0.75 ALDH1A1 (0.50) ALDH1A1HTTTSHRHPGDMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190330264-A1 CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2019-10-31 US disclosed
EP-3506949-A1 CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES Forschungsverbund Berlin E.V. (DE) 2019-07-10 EP disclosed
WO-2018041985-A1 CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES FORSCHUNGSVERBUND BERLIN E.V. (DE) 2018-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330264-A1 CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES PHOSPHO1, PFAS, PNKP ALDH1A1 95/4885HTT 4309/4885TSHR 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.